These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. How should intravenous thrombolytic agents for acute myocardial infarction be selected? Topol EJ Cardiovasc Clin; 1990; 21(1):57-75; discussion 76-8. PubMed ID: 2143103 [No Abstract] [Full Text] [Related]
3. [The choice of appropriate thrombolytic agents as therapy in acute heart infarct]. Görge G; Meyer J Med Klin (Munich); 1992 Feb; 87(2):70-80, 108. PubMed ID: 1542286 [No Abstract] [Full Text] [Related]
4. Safe use of thrombolysis in the elderly. Wittry MD; Thornton TA; Chaitman BR Geriatrics; 1989 Nov; 44(11):28-30, 33-6. PubMed ID: 2509296 [TBL] [Abstract][Full Text] [Related]
5. An overview of the patency and stroke rates following thrombolysis with streptokinase, alteplase, and anistreplase used to treat an acute myocardial infarction. Baxter-Jones CS; White HD; Anderson JL J Interv Cardiol; 1993 Mar; 6(1):15-23. PubMed ID: 10171637 [TBL] [Abstract][Full Text] [Related]
6. [Thrombolytic treatment in acute myocardial infarction. Choice of preparations in Norwegian hospitals]. Andreassen AK; Gullestad L; Endresen K Tidsskr Nor Laegeforen; 1998 Jun; 118(17):2630-1. PubMed ID: 9673511 [TBL] [Abstract][Full Text] [Related]
7. Acylated plasminogen-streptokinase activator complex: a new approach to thrombolytic therapy. Crabbe SJ; Grimm AM; Hopkins LE Pharmacotherapy; 1990; 10(2):115-26. PubMed ID: 2140889 [TBL] [Abstract][Full Text] [Related]
8. [The characteristics of postinfarct stenocardia and the recurrence of a myocardial infarct after thrombolytic therapy]. Chernetsov VA Voen Med Zh; 1998 Sep; 319(9):59-63. PubMed ID: 9817019 [No Abstract] [Full Text] [Related]
9. [Thrombolytic drugs in acute myocardial infarct]. Ambrosioni E; Degli Esposti D Cardiologia; 1991 Dec; 36(12 Suppl 1):395-402. PubMed ID: 1841796 [TBL] [Abstract][Full Text] [Related]
11. Acute myocardial infarction. A guide for North Carolina doctors. Williams ML; O'Meara JJ; Tate DA; Simpson RJ N C Med J; 1995 Aug; 56(8):390-7. PubMed ID: 7566193 [No Abstract] [Full Text] [Related]
12. Thrombolytic therapy in acute myocardial infarction. Paspa PA; Movahed A Am Fam Physician; 1992 Feb; 45(2):640-8. PubMed ID: 1739049 [TBL] [Abstract][Full Text] [Related]
13. Evaluation and comparison of the adverse effects of streptokinase and alteplase. Tisdale JE; Colucci RD; Ujhelyi MR; Kluger J; Fieldman A; Chow MS Pharmacotherapy; 1992; 12(6):440-4. PubMed ID: 1492007 [TBL] [Abstract][Full Text] [Related]
14. [Thrombolysis in acute myocardial infarct]. Görge G; Erbel R Dtsch Med Wochenschr; 1994 May; 119(19):717. PubMed ID: 8187628 [No Abstract] [Full Text] [Related]
16. [Thrombolytic therapy in acute myocardial infarction. Mechanism of action and treatment considerations]. Roguin A; Manaster J; Roguin N Harefuah; 1993 Jun; 124(12):770-5. PubMed ID: 8375772 [No Abstract] [Full Text] [Related]
17. Thrombolytic therapy in acute MI. Weighing the risks and benefits. Ro KG; Anderson HV Postgrad Med; 1990 Dec; 88(8):79-80, 83-6, 89-90 passim. PubMed ID: 2123035 [TBL] [Abstract][Full Text] [Related]
18. Thrombolytic agents for acute evolving myocardial infarction: comparative effects. Sherry S Ration Drug Ther; 1987 Jan; 21(1):1-9. PubMed ID: 3112866 [No Abstract] [Full Text] [Related]
19. [Effects of thrombolytic treatments on the mortality of myocardial infarction. Characteristics of large-scale trials, main results]. Slama M; Cohen-Solal A; Spriet A Arch Mal Coeur Vaiss; 1989 Oct; 82 Spec No 3():27-33. PubMed ID: 2512885 [TBL] [Abstract][Full Text] [Related]